Table 1 Results of MDM2 immunohistochemistry and FISH adjunctive tests on both well-differentiated liposarcomas/atypical lipomatous tumors and a variety of benign lipomatous neoplasms

From: Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?

Category

MDM2 + immunohistochemistry

MDM2 + FISH

No. of cases with autofluorescence

Well-differentiated liposarcoma (n=17)

 Biopsy

11/17 (65%)

11/11 (100%)

6

 Resection

15/17 (88%)

16/17 (94%)

0

Lipoma (n=11)

 Biopsy

1/11 (9%)

0/9 (0%)

2

 Resection

1/11 (9%)

0/11 (0%)

0

Spindle cell/pleomorphic lipoma (n=2)

 Biopsy

1/2 (50%)

0/2 (0%)

0

 Resection

0/2 (0%)

0/2 (0%)

0

Angiolipoma (n=10)

 Biopsy

1/10 (10%)

0/9 (0%)

1

 Resection

0/10 (0%)

0/8 (0%)

2

Dedifferentiated liposarcoma (n=1)

 Biopsy

1/1 (100%)

1/1 (100%)

0

 Resection

1/1 (100%)

1/1 (100%)

0

Myelolipoma (n=1)

 Biopsy

0/1 (0%)

0/1 (0%)

0

 Resection

0/1 (0%)

0/1 (0%)

0

Intramuscular lipoma (n=8)

 Biopsy

0/8 (0%)

0/7 (0%)

1

 Resection

0/8 (0%)

0/8 (0%)

0

Fibrolipoma (n=3)

 Biopsy

0/3 (0%)

0/3 (0%)

0

 Resection

0/3 (0%)

0/3 (0%)

0

Lipoblastoma (n=1)

 Biopsy

0/1 (0%)

0/1 (0%)

0

 Resection

0/1 (0%)

0/1 (0%)

0

Hibernoma (n=1)

 Biopsy

1/1 (100%)

0/0 (N/A)

1

 Resection

0/1 (0%)

0/0 (N/A)

1

All benign lipomatous lesions (n=37)

 Biopsy

4/37 (11%)

0/32 (0%)

5

 Resection

1/37 (3%)

0/34 (0%)

3